Synlab says its revenues will grow 20-25% this year, upping guidance from 17%, as the COVID-19 related tailwind shows no sign of dissipating. It expects to hit up to €3.3bn of sales.
M&A is picking up in the European imaging sector this week with Affidea and Naxicap buying big in Italy and Switzerland, respectively, and a top-five German imaging group reportedly in the middle of a sales process.
The UK government is launching a new data strategy that aims to digitise, connect and transform the health and care sector, recognising the power of data being used to save lives during the pandemic
First-round bids have come in for Italy's largest lab group Lifebrain, with few surprises among the names. It's the second big move in the Italian lab market after Charme Capital confirmed it has bought smaller rival Bianalisi. Multiples in the sector are hitting 16x EBITDA.
The future of the UK NHS is changing according to the recent White Paper and Queen's Speech - we're moving towards collaboration not competition and a Secretary of State for Health with wider powers. But current incumbent Matt Hancock's reputation is damaged and his political capital on the wane. HBI heard at a Kings Fund digital event that this could prove a problem for the NHS.
Europe's largest lab group Synlab continues to see huge COVID-19 driven growth with organic revenue doubling and EBITDA quadrupling in the first quarter. 92% of that growth came from COVID-19 testing.
Synlab's shares have continued to trade in the lower end of the IPO price range since it took to the Frankfurt Stock Exchange last Friday, April 30, opening flat and now around 3% up.
PE firm Mid Europa has pushed back its exit horizon for Romanian healthcare group Regina Maria to 2024 at the earliest, three years later than it planned to pre-Covid. Regina Maria grew revenues 27% in 2020.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
